In murine models of PDAC, BTK inhibition promoted the conversion from an M2-like to M1-like macrophage and the differentiation of CD8 T-cells and was associated with enhanced tumor shrinkage when combined with gemcitabine [43]. This evidence concerns the gene CD8A and neoplasm.